Cervical cancer trials in China

In China 159 Also abroad 532

159 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
Where
Shanghai
Age
18 years to 75 years
People
35
Run by
Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06878222
Phase 2Enrolling by invitation
Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids
Where
Chongqing
Age
18 years and over
People
50
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT06786780
Phase 2Taking people
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Where
Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Hefei, Lanzhou, Nanning, Shenyang, Tianjin, Wuhan
Age
18 years to 70 years
People
40
Run by
Tongji Hospital
See details and how to joinNCT06288360
No phaseNot yet taking people in China
A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
Where
Beijing
Age
18 years to 75 years
People
20
Run by
Peking University Third Hospital
See details and how to joinNCT06882473
No phaseNot yet taking people in China
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer
Where
Shanghai
Age
18 years to 75 years
People
20
Run by
Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06878196
No phaseTaking people
Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis
Where
Shanghai
Age
18 years to 75 years
People
15
Run by
Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06840418
No phaseTaking people
Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
Where
Wuhan
Age
20 years to 60 years
People
10,000
Run by
Zhongnan Hospital
See details and how to joinNCT06082765
Phase 2/3Taking people
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
Where
Wuhan
Age
18 years to 70 years
People
526
Run by
Bio-Thera Solutions
See details and how to joinNCT06123884
No phaseEnrolling by invitation
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Where
Wuhan
Age
18 years to 75 years
People
20
Run by
Ding Ma
See details and how to joinNCT06810895
Phase 2/3Enrolling by invitation
A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Where
Linyi
Age
18 years and over
People
510
Run by
Shandong New Time Pharmaceutical Co., LTD
See details and how to joinNCT06755515
Phase 2Not yet taking people in China
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
Where
Beijing
Age
18 years and over
People
30
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06745219
Phase 2Not yet taking people in China
A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
Where
Shanghai
Age
18 years and over
People
120
Run by
Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06724263
No phaseNot yet taking people in China
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
Where
Hangzhou
Age
26 years to 54 years
People
800
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT06713655
Phase 3Taking people
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Where
Beijing, Shanghai
Age
18 years to 75 years
People
420
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06692166
Phase 2Taking people
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Where
Guangzhou, Wuhan
Age
18 years to 45 years
People
40
Run by
Tongji Hospital
See details and how to joinNCT06289062
Phase 2/3Taking people
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Where
Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Hefei, Lanzhou, Nanning, Shenyang, Tianjin, Wuhan
Age
18 years to 70 years
People
440
Run by
Tongji Hospital
See details and how to joinNCT06288373
Phase 2Taking people
Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
Where
Chongqing
Age
18 years and over
People
33
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT05687851
No phaseTaking people
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
Where
Fuzhou
Age
18 years to 80 years
People
200
Run by
Fujian Cancer Hospital
See details and how to joinNCT06140589
Phase 2Taking people
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Where
Jinan, Wuhan
Age
18 years to 70 years
People
50
Run by
Tongji Hospital
See details and how to joinNCT06289751
Phase 1Taking people
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Where
Qingdao
Age
18 years and over
People
18
Run by
The Affiliated Hospital of Qingdao University
See details and how to joinNCT06544720
No phaseNot yet taking people in China
A Prospective Cohort Study Comparing AI Prediction Model With Imaging Assessment to Diagnose Lymph Node Metastasis in Cervical Cancer
Where
Shanghai
Age
18 years to 80 years
People
230
Run by
Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06541288
No phaseNot yet taking people in China
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Where
Suzhou
Age
18 years to 80 years
People
80
Run by
Geneplus-Beijing Co. Ltd.
See details and how to joinNCT06283875
Phase 2/3Taking people
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Where
Guanzhou
Age
18 years and over
People
200
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739
Phase 1/2Taking people
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 70 years
People
100
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338
Phase 3Taking people
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Where
Liuzhou
Age
20 years to 45 years
People
8,000
Run by
Shanghai Bovax Biotechnology Co., Ltd.
See details and how to joinNCT04422366